On the afternoon of the 18th, President Moon Jae-in is demonstrating a comparison between a general syringe and a minimum residual type syringe at Poonglim Pharmatech, a production facility for the least residual type (LDS) syringe for corona 19 vaccination in Gunsan, Jeollabuk-do. yunhap news
It has been confirmed that the Korean government has not secured the corona 19 vaccination syringe produced by Poonglim Pharmatech, highly praised by President Moon Jae-in. This is because Poonglim Pharmatech did not have a mass production system at the time of signing the vaccine syringe.
Yang Dong-gyo, head of the Resource Management Team of the Corona 19 Vaccination Response Promotion Team, said at a briefing on the day that “the contract to purchase the’minimum residual type (LSD) syringe’ produced by Poonglim Pharmatech has not been signed.”
“We determined that it is important to secure the minimum residual syringes early, so we have been grasping the current status of domestic manufacturers since last January.” “After such a process, we signed a supply contract with two domestic companies on the 26th of last month. I signed it,” he explained.
This means that Poonglim Pharmatech was not intentionally excluded in the process of signing a syringe contract.
However, Yang added, “Punglim Pharmatech has revealed its intention to donate about 120,000 syringes and is expected to be used for initial vaccination.”
In addition, Yang added, “There are two major syringes used for the Corona 19 vaccination, an LDS syringe and a general syringe.”
Poonglim Pharmatech began developing LDS syringes last year, and with the help of Samsung Electronics and the government, it completed from prototype production to mass production in a month. With the support of Samsung Bioepis and the Food and Drug Administration, it was approved for use by the US Food and Drug Administration (FDA) on the 17th.
It is reported that about 260 million syringes are being requested to be purchased in 20 countries including Japan.
Earlier on the 18th, President Moon Jae-in visited the Poonglim Pharmatech production site in Gunsan City, Jeollabuk-do, and said, “Behind the innovation achievements of Poonglim Pharmatech, there was a win-win cooperation between large companies, SMEs, and the government.” This is done,” he encouraged.